Mwa Asset Management Vertex Pharmaceuticals Inc Transaction History
Mwa Asset Management
- $140 Billion
- Q2 2024
A detailed history of Mwa Asset Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mwa Asset Management holds 4,601 shares of VRTX stock, worth $2.25 Million. This represents 1.54% of its overall portfolio holdings.
Number of Shares
4,601
Previous 2,110
118.06%
Holding current value
$2.25 Million
Previous $882 Million
144.51%
% of portfolio
1.54%
Previous 0.64%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,707Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$13.1 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.4 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.74 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.18 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...